Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Expects to Complete Financing Next Week to Help Fund ABI Acquisition

NEW YORK (GenomeWeb News) – Invitrogen said yesterday that it expects to complete within the next seven days a $2.65 billion bank facility to partially fund its roughly $6.7 billion acquisition of Applied Biosystems.
Invitrogen said that the facility, which is being underwritten by Bank of America, UBS, and Morgan Stanley, is “substantially oversubscribed.”
The Carlsbad, Calif.-based firm also said that it is currently engaged with the European Commission regarding European approval of the deal. The acquisition cleared the US antitrust waiting period in late July.
Invitrogen and ABI sent out a joint proxy statement/prospectus regarding the acquisition to shareholders last week. The shareholders of both firms will vote on the deal next month, with closure of the transaction expected in the fourth quarter of this year.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.